Mental health care utilization among men with castration-resistant prostate cancer receiving abiraterone or enzalutamide.
Mental health care utilization among men with castration-resistant prostate cancer receiving abiraterone or enzalutamide. Cancer Med. 2023 08; 12(15):16490-16501.